Manuscripts
Showing 1573 manuscripts.
Development of a directly observed therapy (DOT) adherence intervention for adolescents with HIV-1: application of focus group methodology to inform design, feasibility and acceptability.
Citation
Patricia A. Garvie, Joanne Lawford, Patricia M. Flynn, Aditya Gaur, Marvin Eric Belzer, George D. McSherry, Lawrence B. Friedman, ChengCheng Hu. Development of a directly observed therapy (DOT) adherence intervention for adolescents with HIV-1: application of focus group methodology to inform design, feasibility and acceptability.. Journal of Adolescent Health. 2009. 44: 124-32. PMID: 19167660Year
          2009      
Journal
          Journal of Adolescent Health      
Study
          P1036A      
Allocation of family responsibility for illness management in pediatric HIV.
Citation
Sylvie Naar-King, Grace Montepiedra, Sharon L. Nichols, John J. Farley, Patricia A. Garvie, Betsy Kammerer, Kathleen Malee, Patricia Sirois, Deborah S. Storm. Allocation of family responsibility for illness management in pediatric HIV.. Journal of Pediatrics. 2009. 34: 187-94. PMID: 18586756Year
          2009      
Journal
          Journal of Pediatrics      
Study
          P1042S      
Impact of disclosure of HIV infection on health-related quality of life among children and adolescents with HIV infection.
Citation
Anne Butler, Paige L. Williams, Lois C. Howland, Deborah S. Storm, Nancy Hutton, George Seage. Impact of disclosure of HIV infection on health-related quality of life among children and adolescents with HIV infection.. Pediatrics. 2009. 123: 935-43. PMID: 19255023Year
          2009      
Journal
          Pediatrics      
Morphologic and Metabolic Abnormalities in Vertically HIV-infected Children and Youth: Pediatric AIDS Clinical Trials Group P1045 team
Citation
Grace M. Aldrovandi, Jane C. Lindsey, Denise L. Jacobson, Amanda Zadzilka, Elizabeth Sheeran, John ( Jack ) Moye, Peggy R. Borum, William A. Meyer, Dana S. Hardin, Kathleen Mulligan. Morphologic and Metabolic Abnormalities in Vertically HIV-infected Children and Youth: Pediatric AIDS Clinical Trials Group P1045 team. AIDS. 2009. 23: 661-72. PMID: 19279441Year
          2009      
Journal
          AIDS      
Study
          P1045      
Using Social Networks to Recruit an HIV Vaccine Preparedness Cohort
Citation
Thomas Valente, Jennifer B. Zogg, Jean Richardson, Andrea Kovacs, Eva A. Operskalski. Using Social Networks to Recruit an HIV Vaccine Preparedness Cohort. Journal of Acquired Immune Deficiency Syndromes. 2009. 52: 514-23. PMID: 19584741Year
          2009      
Journal
          Journal of Acquired Immune Deficiency Syndromes      
Abacavir pharmacokinetics during chronic therapy in HIV-1-infected adolescents and young adults.
Citation
John W. Sleasman, Brian Robbins, Shane Cross, Jane C. Lindsey, Barbara E. Heckman, H.G. Sprenger, Nancy Tustin, Charles Rose, Gary E. Pakes, Edmund Capparelli, P Poston, E Neal, M Nikanjam. Abacavir pharmacokinetics during chronic therapy in HIV-1-infected adolescents and young adults.. Clinical Pharmacology & Therapeutics. 2009. 85: 394-401. PMID: 19118380Year
          2009      
Journal
          Clinical Pharmacology & Therapeutics      
Study
          P1052      
Human immunodeficiency virus type-1 infection inhibits autophagy.
Citation
Dejiang Zhou, Stephen A. Spector. Human immunodeficiency virus type-1 infection inhibits autophagy.. AIDS. 2009. 22: 695-9. PMID: 18356598Year
          2009      
Journal
          AIDS      
Increased risk of hepatotoxicity in HIV-infected pregnant women receiving antiretroviral therapy independent of nevirapine exposure
Citation
Susan B Brogly, Audrey L French, Robert M Leighty, Bruce Thompson, Ruth E Tuomala, Ronald C Hershow, David W Ouyang, David E Shapiro, Ming Lu. Increased risk of hepatotoxicity in HIV-infected pregnant women receiving antiretroviral therapy independent of nevirapine exposure. AIDS. 2009. 23: 2425-30. PMID: 19617813Year
          2009      
Journal
          AIDS      
Study
          P1025      
Improvement in lipid profiles over 6 years of follow-up in adults with AIDS and immune reconstitution
Citation
Paige L. Williams, Julia (Wei) Wu, Susan Ellen Cohn, Susan L. Koletar, J. Allen McCutchan, Robert L. Murphy, Judith Silverstein Currier. Improvement in lipid profiles over 6 years of follow-up in adults with AIDS and immune reconstitution. HIV Medicine. 2009. 10: 290-301.Year
          2009      
Journal
          HIV Medicine      
Predictive value of pharmacokinetics-adjusted phenotypic susceptibility on response to ritonavir-enhanced protease inhibitors (PIs) in human immunodeficiency virus-infected subjects failing prior PI therapy
Citation
Joseph J. Eron, Jeong-Gun Park, Richard H. Haubrich, Francesca Aweeka, Barbara Bastow, Gary E. Pakes, Song Yu, Hulin Wu, Douglas D. Richman. Predictive value of pharmacokinetics-adjusted phenotypic susceptibility on response to ritonavir-enhanced protease inhibitors (PIs) in human immunodeficiency virus-infected subjects failing prior PI therapy. Antimicrobial Agents and Chemotherapy. 2009. 53: 2335-41.Year
          2009      
Journal
          Antimicrobial Agents and Chemotherapy